CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in the adoption of single-use technologies for continuous manufacturing
4.1.2. Lower risk of cross-contamination and reduced manufacturing costs
4.1.3. Increase in demand for single-use technologies in biomanufacturing
4.1.4. Increasing demand for flexible bioprocessing equipment with less floor space
requirements
4.2. Market Restraints & Challenges
4.2.1. Growing concerns related to leachable and extractable
4.2.2. Strict regulations about the use of disposable bioprocessing systems
4.3. Market Opportunities
4.3.1. Rising number of acquisitions
4.3.2. Developing markets with untapped growth potential
4.3.3. Patent Expiry
CHAPTER 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET – BY PRODUCT
5.1. Media Bags and Containers
5.2. Filtration Assemblies
5.3. Disposable/Single-Use Bioreactors
5.4. Disposable Mixers
CHAPTER 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET – BY METHOD
6.1. Filtration
6.2. Storage
6.3. Cell Culture
6.4. Mixing
6.5. Purification
CHAPTER 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET – BY MATERIAL
7.1. Plastic
7.1.1. Polyethene
7.1.2. Polyvinyl Chloride
7.1.3. Polyamide
7.2. Silicone
7.3. Others
CHAPTER 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET – BY
APPLICATION
8.1. Monoclonal Antibody Production
8.2. Vaccine Production
8.3. Plant Cell Cultivation
8.4. Patient-Specific Cell Therapies
CHAPTER 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET – BY END USER
9.1. Biopharmaceutical Manufacturers
9.2. Life Science R&D
CHAPTER 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET - BY
GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET - COMPANY
PROFILES
11.1. Cesco Bio Engineering Co. Ltd
11.2. Applikon Biotechnology B.V
11.3. Thermo Fisher Scientific Inc.
11.4. GE Healthcare
11.5. Sartorius Stedim Biotech S.A.
11.6. Merck Millipore
11.7. Danaher Corporation
11.8. 3M Company
11.9. Eppendorf AG
11.10. Finesse Solutions, Inc.
11.11. Broadley-James Ltd.
11.12. PBS Biotech, Inc.
11.13. Sartorius Stedim Biotech S.A
11.14. Tarpon Biosystems Inc.
11.15. STI Components Inc.
CHAPTER 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET COMPETITIVE
LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13. MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14. APPENDIX
14.1. List of Tables
14.2. List of Figures
